Feedback (LON:FDBK) Trading Up 16.6% – What’s Next?

Feedback plc (LON:FDBK) shot up 16.6% during trading on Friday . The stock traded as high as GBX 14.50 and last traded at GBX 14.40. 576,048 shares were traded during trading, an increase of 370% from the average session volume of 122,489 shares. The stock had previously closed at GBX 12.35.

Feedback Stock Performance

The firm’s 50 day simple moving average is GBX 12.67 and its 200 day simple moving average is GBX 10.70. The firm has a market capitalization of £6.31 million, a price-to-earnings ratio of -0.91 and a beta of 0.77.

Feedback (LON:FDBK) last announced its quarterly earnings data on Tuesday, February 17th. The company reported GBX (3.98) EPS for the quarter. Feedback had a negative net margin of 845.25% and a negative return on equity of 135.17%. As a group, sell-side analysts forecast that Feedback plc will post -8 earnings per share for the current year.

Feedback Company Profile

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.